059210 — Metabiomed Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapContrarian

Market Cap
KR₩109bn
Enterprise Value
KR₩115bn
Revenue
KR₩103bn

Annual balance sheet for Metabiomed Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	15,916	19,141	16,810	54,298	37,863
Net Total Accounts Receivable
Net Total Receivables	13,047	14,504	14,534	17,279	19,949
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	48,203	50,976	49,924	93,957	82,814
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	39,278	52,123	59,086	64,099	76,904
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	103,128	121,072	130,124	177,295	186,604
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	38,161	44,817	44,471	73,597	59,631
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	44,805	60,481	60,077	83,956	62,287
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	58,323	60,591	70,048	93,339	124,316
Total Liabilities & Shareholders' Equity	103,128	121,072	130,124	177,295	186,604
Total Common Shares Outstanding